questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Cyclic Nucleotide-Regulated Protein Kinases
Cyclic GMP-Dependent Protein Kinases
Cyclic GMP-Dependent Protein Kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
GMP cyclique
Tests de laboratoire
Kinases
Essais enzymatiques
Symptômes
5
Troubles neurologiques
Kinases
Fonction cardiaque
Kinases
Maladies cardiovasculaires
Kinases
Troubles de l'humeur
Kinases
Traitements
5
Thérapies géniques
Kinases
Plantes médicinales
Kinases
Complications
5
Troubles de la coagulation
Kinases
Troubles respiratoires
Kinases
Facteurs de risque
5
Facteurs de risque
Kinases
Antécédents familiaux
Kinases
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-Dependent Protein Kinases : Questions médicales les plus fréquentes",
"headline": "Cyclic GMP-Dependent Protein Kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cyclic GMP-Dependent Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D017867",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type I",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type I",
"url": "https://questionsmedicales.fr/mesh/D062965",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type I",
"code": {
"@type": "MedicalCode",
"code": "D062965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type II",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type II",
"url": "https://questionsmedicales.fr/mesh/D062967",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type II",
"code": {
"@type": "MedicalCode",
"code": "D062967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases",
"alternateName": "Cyclic GMP-Dependent Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017869",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fengyang Li",
"url": "https://questionsmedicales.fr/author/Fengyang%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ute Römling",
"url": "https://questionsmedicales.fr/author/Ute%20R%C3%B6mling",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stepan Gambaryan",
"url": "https://questionsmedicales.fr/author/Stepan%20Gambaryan",
"affiliation": {
"@type": "Organization",
"name": "Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg 194223, Russia."
}
},
{
"@type": "Person",
"name": "Roshni R Kharadi",
"url": "https://questionsmedicales.fr/author/Roshni%20R%20Kharadi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
},
{
"@type": "Person",
"name": "George W Sundin",
"url": "https://questionsmedicales.fr/author/George%20W%20Sundin",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Clinically Selected Staphylococcus aureus",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37184389",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/aac.00328-23"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staphylococcus aureus adhesion to the host.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35705378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/nyas.14807"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staphylococcus aureus bacteremia in alcoholics.",
"datePublished": "2024-05-21",
"url": "https://questionsmedicales.fr/article/38771740",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0298612"
}
},
{
"@type": "ScholarlyArticle",
"name": "Update on Staphylococcus aureus bacteraemia.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/35942696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MCC.0000000000000974"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phages for treatment of Staphylococcus aureus infection.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37739558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/bs.pmbts.2023.03.027"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017867"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cyclic GMP-Dependent Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017869"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cyclic GMP-Dependent Protein Kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment diagnostiquer une dysfonction des kinases cGMP ?\nQuels tests sont utilisés pour mesurer le cGMP ?\nQuels symptômes indiquent un problème avec les kinases cGMP ?\nLes tests génétiques sont-ils utiles pour les kinases cGMP ?\nComment évaluer l'activité des kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Staphylococcus+aureus#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les symptômes d'une déficience en kinases cGMP ?\nLes troubles neurologiques sont-ils liés aux kinases cGMP ?\nComment les kinases cGMP affectent-elles la fonction cardiaque ?\nY a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?\nLes troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Staphylococcus+aureus#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment prévenir les troubles liés aux kinases cGMP ?\nL'alimentation influence-t-elle les kinases cGMP ?\nLe stress a-t-il un impact sur les kinases cGMP ?\nLes examens réguliers sont-ils importants ?\nL'exercice physique aide-t-il à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Staphylococcus+aureus#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels traitements ciblent les kinases cGMP ?\nLes médicaments augmentant le cGMP sont-ils efficaces ?\nComment les thérapies géniques peuvent-elles aider ?\nY a-t-il des traitements naturels pour les dysfonctionnements cGMP ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Staphylococcus+aureus#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?\nLes troubles de la coagulation sont-ils liés aux kinases cGMP ?\nY a-t-il des risques de cancer associés aux kinases cGMP ?\nLes maladies rénales peuvent-elles être influencées par cGMP ?\nLes troubles respiratoires sont-ils liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Staphylococcus+aureus#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?\nL'âge influence-t-il la fonction des kinases cGMP ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Staphylococcus+aureus#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des kinases cGMP ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses génétiques peuvent être utilisés pour évaluer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer le cGMP ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages immunologiques et des tests enzymatiques peuvent mesurer les niveaux de cGMP dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les kinases cGMP ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme des troubles cardiovasculaires ou neurologiques peuvent indiquer un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les kinases cGMP ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant les kinases cGMP."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité des kinases cGMP ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité peut être évaluée par des essais enzymatiques spécifiques in vitro."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en kinases cGMP ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles de la circulation sanguine et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés aux kinases cGMP ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent contribuer à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les kinases cGMP affectent-elles la fonction cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles régulent la relaxation et la contraction cardiaque, influençant la pression artérielle."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes spécifiques peuvent inclure des douleurs thoraciques et des palpitations."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études suggèrent un lien entre les kinases cGMP et la régulation de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux kinases cGMP ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et surveiller les facteurs de risque cardiovasculaires aide à prévenir."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les kinases cGMP ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut soutenir la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les kinases cGMP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des dysfonctionnements cGMP."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la signalisation cGMP et la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les kinases cGMP ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques et des modulateurs de cGMP sont utilisés pour traiter certaines conditions."
}
},
{
"@type": "Question",
"name": "Les médicaments augmentant le cGMP sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les nitrates et les inhibiteurs de la phosphodiestérase peuvent être efficaces."
}
},
{
"@type": "Question",
"name": "Comment les thérapies géniques peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques peuvent corriger des mutations dans les gènes des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour les dysfonctionnements cGMP ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent avoir des effets bénéfiques sur la signalisation cGMP."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation saine et l'exercice peuvent améliorer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des maladies cardiovasculaires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la coagulation sont-ils liés aux kinases cGMP ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent affecter la coagulation sanguine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés aux kinases cGMP ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les dysfonctionnements cGMP et le développement du cancer."
}
},
{
"@type": "Question",
"name": "Les maladies rénales peuvent-elles être influencées par cGMP ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les kinases cGMP jouent un rôle dans la régulation de la fonction rénale."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils liés aux kinases cGMP ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans la signalisation cGMP peuvent contribuer à des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fonction des kinases cGMP ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque de dysfonctionnement des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la signalisation cGMP et augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
3 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg 194223, Russia.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Clinical Pathology and Bio-safety Research Institute, College of Veterinary Medicine, Chonbuk National University, Jeonju, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
BK21Plus Program for 21st Century Biomedical Science Leader Development, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
Daptomycin is a last-resort antibiotic used for the treatment of infections caused by Gram-positive antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Treatment...
Staphylococcus aureus is a pathobiont capable of colonizing and infecting most tissues within the human body, resulting in a multitude of different clinical outcomes. Adhesion of S. aureus to the host...
Alcoholism associates with increased Staphylococcus aureus bacteremia incidence and mortality. The objective was to compare disease progression, treatment and prognosis of Staphylococcus aureus bacter...
The study design was a multicenter retrospective analysis of methicillin-sensitive Staphylococcus aureus bacteremia with 90-day follow-up. Patients were stratified as alcoholics or non-alcoholics base...
Alcoholics, versus non-alcoholics, were younger, typically male and more commonly had community-acquired Staphylococcus aureus bacteremia. No differences in McCabe´s classification of underlying condi...
Alcoholism deteriorates Staphylococcus aureus bacteremia prognosis, and our results suggests that this is predominantly through illness severity at bacteremia onset. Three quarters of Staphylococcus a...
To review recently published evidence relevant to Staphylococcus aureus bacteremia (SAB)....
Staphylococcus aureus is the most common pathogen causing co-infections and superinfections in patients with COVID-19. Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia ratios have sharply...
Our review confirms that Staphylococcus aureus represents a special aetiology among all causes of bloodstream infections. Pending results of platform and larger trials, its distinct epidemiology and d...
Combating multi-drug resistant bacterial infections should be a universal urgency. The gram- positive Staphylococcus aureus (S. aureus) bacteria are generally harmless; healthy people frequently have ...
Staphylococcus aureus is a common clinical pathogen. Does every S. aureus infection require anti-MRSA drugs? Reported here are three cases of a community-acquired infection with S. aureus. The first c...
Staphylococcus aureus bacteremia patients characteristics at a tertiary hospital are described, and complications, mortality and associated factors are analyzed....
Data from patients with S. aureus bacteremia admitted between March 2020 and February2021 at Miguel Servet university hospital in Zaragoza were retrospectively analyzed....
Results showed a 14 days mortality of 24.2% and an 30 days mortality of 40%. Overall survival decreased with complications appearance [HR 3.1 (1.2-8.05)] and age over 65 years [HR 3.1 (1.4-6.6)]. The ...
High 14- and 30-days mortality were found, as well as a worse evolution in older age patients, with sepsis presence, and with greater number of positive blood cultures and times to positive blood cult...
Pseudomonas aeruginosa inhibits or eradicates Staphylococcus aureus in most in vitro settings. Nonetheless, P. aeruginosa and S. aureus are commonly isolated from chronically infected, nonhealing woun...
The spread of antibiotic resistance is attracting increased attention to combination-based treatments. Although drug combinations have been studied extensively for their effects on bacterial growth...
Staphylococcus aureus is an uncommon cause of community-acquired bacterial meningitis. We aimed to describe patients with this disease....
We evaluated clinical characteristics and outcome of adults with community-acquired S. aureus meningitis from prospective nationwide cohort studies from Denmark (2015-2020) and the Netherlands (2006-2...
We evaluated 111 episodes of community-acquired S. aureus meningitis: 65 from Denmark and 46 from the Netherlands. The median age was 66 years (interquartile range [IQR] 50-74) and 43 of 111 patients ...
Community-acquired S. aureus meningitis is a severe disease with a high case fatality rate, occurring mainly in patients with concomitant endocarditis or spondylodiscitis....